New vaccine strategy aims to outsmart drug-resistant ovarian cancer
Disease control
Not yet recruiting
This study tests whether a cancer vaccine (NY-ESO-1) given before immunotherapy (anti-PD-1) can prevent the cancer from becoming resistant to treatment. It includes 24 women with advanced ovarian cancer that has stopped responding to standard chemotherapy. The goal is to see if t…
Phase: PHASE2 • Sponsor: Georgetown University • Aim: Disease control
Last updated May 15, 2026 11:55 UTC